A Phase 1 Trial of 2 Dose Schedules of ABT-510, an Antiangiogenic, Thrombospondin-1-mimetic Peptide, in Patients With Advanced CancerGORDON, Michael S; MENDELSON, David; CARR, Robert et al.Cancer. 2008, Vol 113, Num 12, pp 3420-3429, issn 0008-543X, 10 p.Article

Investigation of the immunogenicity of a protein drug using equilibrium dialysis and liquid chromatography tandem mass spectrometry detectionJI, Qin C; RODILA, Ramona; MORGAN, Sherry J et al.Analytical chemistry (Washington, DC). 2005, Vol 77, Num 17, pp 5529-5533, issn 0003-2700, 5 p.Article

Phase I dose-escalation study of the safety and pharmacokinetics of atrasentan: An endothelin receptor antagonist for refractory prostate cancerZONNENBERG, Bernard A; GROENEWEGEN, Gerard; JANUS, Todd J et al.Clinical cancer research. 2003, Vol 9, Num 8, pp 2965-2972, issn 1078-0432, 8 p.Article

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: A randomized, phase II, placebo-controlled trialCARDUCCI, Michael A; PADLEY, Robert J; SCHMITT, Jennifer L et al.Journal of clinical oncology. 2003, Vol 21, Num 4, pp 679-689, issn 0732-183X, 11 p.Article

Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung CancerRUDIN, Charles M; HANN, Christine L; RANSON, Malcolm R et al.Clinical cancer research (Print). 2012, Vol 18, Num 11, pp 3163-3169, issn 1078-0432, 7 p.Article

Phase 2 Study of ABT-510 in Patients with Previously Untreated Advanced Renal Cell CarcinomaEBBINGHAUS, Scot; HUSSAIN, Maha; TANNIR, Nizar et al.Clinical cancer research. 2007, Vol 13, Num 22, pp 6689-6695, issn 1078-0432, 7 p., 1Article

Randomized, Phase II Study of the Thrombospondin-1-Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Soft Tissue SarcomaBAKER, Laurence H; ROWINSKY, Eric K; MENDELSON, David et al.Journal of clinical oncology. 2008, Vol 26, Num 34, pp 5583-5588, issn 0732-183X, 6 p.Article

Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondm-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancerHOEKSTRA, Ronald; DE VOS, Filip Y. F. L; DE VRIES, Elisabeth G. E et al.Journal of clinical oncology. 2005, Vol 23, Num 22, pp 5188-5197, issn 0732-183X, 10 p.Article